Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Aromatic amino acids in the brain
| Aromatic amino acids in the brain |
| Pubbl/distr/stampa | Amsterdam ; ; New York : , : Elsevier, , 1974 |
| Descrizione fisica | 1 online resource (408 pages) : illustrations, maps |
| Disciplina | 599/.01/88 |
| Collana | Ciba Foundation symposium (new series) |
| Soggetto topico |
Amino acids
Brain chemistry Aromatic compounds |
| ISBN |
1-280-78342-7
9786613693815 0-470-72005-0 0-470-71772-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Aromatic Amino Acids in the Brain; Contents; Chairman's introduction; Control of plasma amino acid concentrations; Discussion; Amino acid transport in the brain in vivo and in vitro; Discussion; Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain; Discussion; Tyrosine aminotransferase in the brain; Discussion; Properties of pterin-dependent aromatic amino acid hydroxylases; Discussion; The in vivo estimation of rates of tryptophan and tyrosine hydroxylation: effects of alterations in enzyme environment and neuronal activity; Discussion
The regulation of tyrosine hydroxylase activity in adrenergic nervous tissue Discussion; Nutritional control of the synthesis of 5-hydroxytryptamine in the brain; Discussion; The transfer of tryptophan across the synaptosome membrane; Discussion; Tryptophan concentration in the brain; Serum free tryptophan: control of brain concentrations of tryptophan and of synthesis of 5-hydroxytryptamine; Fatty acids and the disposition of tryptophan; Discussion of the three preceding papers Monoamine metabolites in the cerebrospinal fluid: indicators of the biochemical status of monoaminergic neurons in the cerebral nervous system Discussion; Do tryptophan concentrations limit protein synthesis at specific sites in the brain?; Discussion; Aromatic amino acid supply and protein synthesis in the brain; Discussion; Effects of amino acid imbalance on amino acid utilization, protein synthesis and polyribosome function in cerebral cortex; Discussion; L-Dopa, polysomal aggregation and cerebral synthesis of protein; Discussion; a-Methyldopa, an unnatural aromatic amino acid Synthetic p-halogenophenylalanines and protein synthesis in the brain Discussion; Effects of a-methyltryptophan on tryptophan, 5-hydroxytryptamine and protein metabolism in the brain; Discussion; Chairman's closing remarks; Index of contributors; Subject index |
| Record Nr. | UNINA-9910144662903321 |
| Amsterdam ; ; New York : , : Elsevier, , 1974 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Aromatic amino acids in the brain
| Aromatic amino acids in the brain |
| Pubbl/distr/stampa | Amsterdam ; ; New York : , : Elsevier, , 1974 |
| Descrizione fisica | 1 online resource (408 pages) : illustrations, maps |
| Disciplina | 599/.01/88 |
| Collana | Ciba Foundation symposium (new series) |
| Soggetto topico |
Amino acids
Brain chemistry Aromatic compounds |
| ISBN |
1-280-78342-7
9786613693815 0-470-72005-0 0-470-71772-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Aromatic Amino Acids in the Brain; Contents; Chairman's introduction; Control of plasma amino acid concentrations; Discussion; Amino acid transport in the brain in vivo and in vitro; Discussion; Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain; Discussion; Tyrosine aminotransferase in the brain; Discussion; Properties of pterin-dependent aromatic amino acid hydroxylases; Discussion; The in vivo estimation of rates of tryptophan and tyrosine hydroxylation: effects of alterations in enzyme environment and neuronal activity; Discussion
The regulation of tyrosine hydroxylase activity in adrenergic nervous tissue Discussion; Nutritional control of the synthesis of 5-hydroxytryptamine in the brain; Discussion; The transfer of tryptophan across the synaptosome membrane; Discussion; Tryptophan concentration in the brain; Serum free tryptophan: control of brain concentrations of tryptophan and of synthesis of 5-hydroxytryptamine; Fatty acids and the disposition of tryptophan; Discussion of the three preceding papers Monoamine metabolites in the cerebrospinal fluid: indicators of the biochemical status of monoaminergic neurons in the cerebral nervous system Discussion; Do tryptophan concentrations limit protein synthesis at specific sites in the brain?; Discussion; Aromatic amino acid supply and protein synthesis in the brain; Discussion; Effects of amino acid imbalance on amino acid utilization, protein synthesis and polyribosome function in cerebral cortex; Discussion; L-Dopa, polysomal aggregation and cerebral synthesis of protein; Discussion; a-Methyldopa, an unnatural aromatic amino acid Synthetic p-halogenophenylalanines and protein synthesis in the brain Discussion; Effects of a-methyltryptophan on tryptophan, 5-hydroxytryptamine and protein metabolism in the brain; Discussion; Chairman's closing remarks; Index of contributors; Subject index |
| Record Nr. | UNISA-996202084203316 |
| Amsterdam ; ; New York : , : Elsevier, , 1974 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Aromatic amino acids in the brain
| Aromatic amino acids in the brain |
| Pubbl/distr/stampa | Amsterdam ; ; New York : , : Elsevier, , 1974 |
| Descrizione fisica | 1 online resource (408 pages) : illustrations, maps |
| Disciplina | 599/.01/88 |
| Collana | Ciba Foundation symposium (new series) |
| Soggetto topico |
Amino acids
Brain chemistry Aromatic compounds |
| ISBN |
1-280-78342-7
9786613693815 0-470-72005-0 0-470-71772-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Aromatic Amino Acids in the Brain; Contents; Chairman's introduction; Control of plasma amino acid concentrations; Discussion; Amino acid transport in the brain in vivo and in vitro; Discussion; Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain; Discussion; Tyrosine aminotransferase in the brain; Discussion; Properties of pterin-dependent aromatic amino acid hydroxylases; Discussion; The in vivo estimation of rates of tryptophan and tyrosine hydroxylation: effects of alterations in enzyme environment and neuronal activity; Discussion
The regulation of tyrosine hydroxylase activity in adrenergic nervous tissue Discussion; Nutritional control of the synthesis of 5-hydroxytryptamine in the brain; Discussion; The transfer of tryptophan across the synaptosome membrane; Discussion; Tryptophan concentration in the brain; Serum free tryptophan: control of brain concentrations of tryptophan and of synthesis of 5-hydroxytryptamine; Fatty acids and the disposition of tryptophan; Discussion of the three preceding papers Monoamine metabolites in the cerebrospinal fluid: indicators of the biochemical status of monoaminergic neurons in the cerebral nervous system Discussion; Do tryptophan concentrations limit protein synthesis at specific sites in the brain?; Discussion; Aromatic amino acid supply and protein synthesis in the brain; Discussion; Effects of amino acid imbalance on amino acid utilization, protein synthesis and polyribosome function in cerebral cortex; Discussion; L-Dopa, polysomal aggregation and cerebral synthesis of protein; Discussion; a-Methyldopa, an unnatural aromatic amino acid Synthetic p-halogenophenylalanines and protein synthesis in the brain Discussion; Effects of a-methyltryptophan on tryptophan, 5-hydroxytryptamine and protein metabolism in the brain; Discussion; Chairman's closing remarks; Index of contributors; Subject index |
| Record Nr. | UNINA-9910819041603321 |
| Amsterdam ; ; New York : , : Elsevier, , 1974 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Brain peptides / edited by Dorothy T. Krieger, Michael J. Brownstein, Joseph B. Martin
| Brain peptides / edited by Dorothy T. Krieger, Michael J. Brownstein, Joseph B. Martin |
| Pubbl/distr/stampa | New York : Wiley, c1983 |
| Descrizione fisica | xi, 1032 p. : ill. ; 25 cm |
| Disciplina | 612.8042 |
| Altri autori (Persone) |
Krieger, Dorothy T.
Brownstein, Michael J. Martin, Joseph B. |
| Soggetto topico |
Brain chemistry
Neuropeptides Brain - Physiology Peptides - Physiology |
| ISBN | 0471094331 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISALENTO-991003176239707536 |
| New York : Wiley, c1983 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. del Salento | ||
| ||
Brain-iron cross talk / / edited by Wael Mohamed, Nicola Luigi Brogazzi, and Richard M. Kostrzewa
| Brain-iron cross talk / / edited by Wael Mohamed, Nicola Luigi Brogazzi, and Richard M. Kostrzewa |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2023] |
| Descrizione fisica | 1 online resource (289 pages) |
| Disciplina | 599.0188 |
| Collana | Nutritional Neurosciences |
| Soggetto topico |
Iron - Physiological effect
Brain chemistry |
| ISBN | 981-19-7327-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Acknowledgments -- Contents -- Editors and Contributors -- Part I: Iron, Brain Function and Behavior -- Chapter 1: Iron and Neuro-Cognition -- 1 Introduction -- 2 Delicate Regulation of Iron in the Brain -- 3 Iron Buildup and Neurodegenerative Diseases -- 3.1 Friedreich´s Ataxia -- 3.2 Wilson´s Disease -- 3.3 Alzheimer´s Disease (AD) -- 3.4 Case Study -- 4 Brain Running Short on Iron -- 4.1 Iron Deficiency and Neurotransmitters Synthesis, Signaling, and Energy Demand -- 4.2 Neurons Insulation (Myelination) -- 4.3 Developmental Delays -- 4.4 ADHD -- 4.5 RLS -- 4.6 Effect of Iron on the Dopaminergic and Serotonergic System -- 5 Brain Iron Research Has a Way to Go -- 6 Conclusion -- References -- Chapter 2: The Interplay between Iron and Oxidative Stress in Brain Neurodegenerative Diseases -- 1 Iron as an Essential Micronutrient -- 1.1 Introduction -- 1.2 Dietary Sources, Forms and Requirements of Iron -- 1.2.1 Iron Dietary Sources -- 1.2.2 Iron Forms -- 1.2.3 Human Requirements of Iron -- 1.3 Iron Bioavailability -- 1.4 Iron Metabolism -- 1.4.1 Iron Uptake, Absorption, and Transportation -- 1.4.2 Iron Utilization, Circulation, Reutilization, and Storage -- 1.4.3 Iron Excretion and Regulation -- 1.5 Brain Iron -- 2 Oxidative Stress, Iron Overload, and Brain Degenerative Diseases -- 2.1 The Concept of Oxidative Stress and Redox Signaling -- 2.2 The Crosstalk Between Iron and Redox Signaling and the Consequences of Iron Homeostasis Impairment -- 2.3 Iron Overload, Oxidative Stress, and Brain Degenerative Diseases (Selective Cases) -- 3 Conclusion -- References -- Chapter 3: Specific Nutritional Therapeutic Approaches Targeting Iron Overload and Other Hallmarks of Brain Degenerative Disea... -- 1 Therapeutic Opportunities from Nutritional Point of View -- 1.1 Introduction -- 1.2 Nutritional Therapeutic Opportunities.
1.2.1 Nutritional Treatment of Iron Overload -- Iron Chelators -- Natural Antioxidants -- 1.2.2 Diet Modification -- Diets Rich in Iron Chelators, Antioxidants, and Neurogenerative Molecules -- Caloric Restriction Diets -- Mediterranean Diet -- Gut Microbiota -- 2 Iron Between Deficiency and Overload -- 3 Conclusion -- References -- Chapter 4: Mediterranean Diet and Neuro-Cognition: Focus on Alzheimer Disease -- 1 Introduction -- 2 Mediterranean Diet and Cognitive Health -- 3 Mediterranean Diet and Alzheimer Disease -- 3.1 Fish, Dietary Fatty Acids and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.2 Olive Oil and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.3 Dairy Products and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.4 Tea, Coffee and Risk of Cognitive Decline and Alzheimer´s Disease -- 3.5 Fruits, Vegetables and Risk of Cognitive Decline and Alzheimer´s Disease -- 4 Possible Mechanisms of Mediterranean Diet -- 5 Conclusion -- References -- Part II: Brain Disorders Related to Iron -- Chapter 5: The Critical Roleplay of Iron Neurochemistry in Progression of Parkinson´s Disease -- 1 Introduction -- 2 Brain Iron Transport -- 2.1 Overview of Iron Movement across Brain -- 2.2 Astrocyte Iron Movement -- 2.3 Oligodendrocytes (Transferrin Secretion) -- 2.4 Microglia -- 3 Iron Metabolism in Brain -- 3.1 Absorption -- 3.2 Storage -- 3.3 Brain Iron Toxicity and Accumulation -- 4 Gut Microbiota: A Bridging Stone Between Iron Metabolism and Neurodegeneration -- 5 Biochemical Pathways Accelerating Iron Aggregation -- 5.1 Disabled Iron Discharge -- 5.2 Modified Iron Deposition -- 5.3 Enhanced Iron Influx -- 6 Altered Neurobiology of Iron in PD -- 6.1 Abnormal Iron Homeostasis under Pathophysiological Condition of PD -- 6.2 Interconnection Between Iron and Alpha Synuclein -- 6.3 Ubiquitin-Proteasome System Induced Cell Death. 6.4 How Oxidative Stress Is Linked to Iron Imbalance -- 7 Ferroptosis -Cell Death Pathway in PD Utilizing Iron -- 8 Treatment Strategies for Parkinson´s Disease Targeting Iron Homeostasis -- 8.1 Iron Chelators: A Promising Treatment for PD -- 9 Conclusions and Future Prospects -- References -- Chapter 6: Iron-Calcium Crosstalk in Neurodegenerative Diseases -- 1 Introduction -- 2 Iron -- 2.1 Homeostasis and Repercussion of Altered Concentration of Brain Iron -- 2.2 Brain Anomalies and Iron -- 3 Calcium -- 3.1 Homeostasis and Repercussion of Altered Concentration of Brain Calcium -- 3.2 Brain Anomalies and Calcium -- 4 Calcium-Iron Crosstalk: A Strange Phenomenon -- 5 Ferroptosis: A Cell Death -- 5.1 Iron Balancing in Ferroptosis -- 5.2 Calcium and Iron Induced Cell Death: Play Collective Role in Oxytosis or Ferroptosis -- 6 Connecting Link to Neurodegeneration: Iron, Calcium, and Ferroptosis -- 6.1 Pantothenate Kinase-Associated Neurodegeneration (PKAN) -- 6.2 Calcineurin -- 6.3 Ryanodine Receptor -- 6.4 Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) -- 7 Conclusion -- References -- Chapter 7: Iron and Alzheimer´s Disease -- 1 Introduction -- 2 Alzheimer´s Disease -- 2.1 Pathogenesis -- 2.2 Symptoms and Treatments -- 3 Brain Iron Metabolism -- 3.1 What Is Iron? -- 3.2 Iron Absorption and Transport into the Brain -- 3.3 Iron Regulation in the Brain -- 4 Iron and Alzheimer´s Disease: What Is the Interplay? -- 5 Conclusion -- References -- Chapter 8: Iron and Multiple Sclerosis -- 1 Introduction -- 2 Brain-Iron Homeostasis -- 2.1 Iron Uptake in the Brain -- 3 Imaging and Brain Iron in Multiple Sclerosis -- 4 Disruption of Iron Homeostasis in Multiple Sclerosis -- 4.1 Iron Accumulation in Brain -- 4.2 Ferroptosis: Tissue Damage Via Iron Accumulation -- 5 Astrocytes -- 6 Oligodendrocytes -- 7 Grey Matter Iron Accumulation. 8 White Matter Iron Deposition -- 9 Iron Genetic Relation in Multiple Sclerosis -- 10 Iron Chelation Therapy in Multiple Sclerosis -- 11 Chelation Therapy in EAE Model of Multiple Sclerosis -- 11.1 Impact of Brain Iron Accumulation on Cognition and Memory -- 11.2 Brain Iron in Fetus Development -- 11.3 Association of Aging to Iron Induced Neurodegeneration -- 12 Conclusion -- References -- Chapter 9: Iron and Epilepsy -- 1 Introduction -- 1.1 Epilepsy- a Neurological Disorder -- 1.2 Epilepsy Prevalence around the World -- 1.3 Epilepsy in Adults -- 1.4 Risk Factors of Epilepsy -- 1.5 Epilepsy Classification -- 1.6 Seizure -- 1.6.1 The Structure of Classification -- 1.6.2 Classification of Seizure -- 1.6.3 Seizures Are further Classified into Three Based on the Onset (Auvin, 2018) -- 2 Mortality in Epilepsy -- 3 Neuropathology of Epileptic Seizures -- 4 Iron in Brain -- 5 Modulation of Erythropoiesis in the Blood-Brain Barrier (BBB) -- 6 Brain Iron Deposition and Neuronal Death -- 7 Iron in Epilepsy -- 8 Epilepsy Induced by Iron -- 9 Iron Metabolic Process in Epilepsy -- 10 Histopathological Changes in the Epileptic Brain Tissue -- 11 Histopathological Changes in the Iron Induced Epileptic Brain Tissue -- 12 Management of Epilepsy -- 12.1 Initial Management of Epilepsy -- 12.2 Diagnosis of Epilepsy -- 12.3 Pharmaceutical Intervention -- 12.4 Few Common Antiepileptic Drugs (AEDs) -- 12.5 Common Basic Issues Using Anti-Epileptic Drugs -- 12.6 Epilepsy that Is Resistant to Medication -- 12.7 Surgical Therapy -- 12.8 Alternative Treatment Options -- 12.9 Precision Medicine -- 13 Treatment of Epilepsy Induced by Iron -- 14 Conclusion -- References -- Chapter 10: Iron and Subarachnoid Hemorrhage -- 1 Introduction to Subarachnoid Hemorrhage (SAH) -- 2 Epidemiology -- 3 Signs and Symptoms -- 4 Introduction to Iron -- 5 Overview of the Anatomy of Brain. 6 Homeostasis of Iron in the Brain -- 7 Early Brain Injury Post-SAH -- 8 Cerebral Vasospasm Post-SAH -- 9 Role of Iron after SAH -- 10 Body´s Defense against Unbound Heme -- 11 SAH Markers -- 11.1 Hepcidin -- 11.2 Haptoglobin -- 11.3 Haptoglobin Genotype -- 11.4 Total Iron Binding Capacity -- 12 Other Markers -- 13 Heme-Oxygenase 1 -- 14 Ferroptosis -- 15 Biomarker for Ferroptosis -- 16 Ferroptosis and GPX4 -- 17 Ferroptosis and Liproxstatin-1 -- 18 Intracerebral Iron Accumulation -- 19 SAH and Acute Seizures -- 20 SAH and Acute Hydrocephalus -- 21 MRI-QSM (Magnetic Resonance Imaging-Quantitative Susceptibility Mapping) -- 22 Nimodipine and Deferoxamine -- 23 Treatment of Neurotoxicity Caused by HB with Vitreous -- 24 Heat Shock Protein (HSP) and SAH -- 25 Conclusion -- References -- Chapter 11: Iron Deficiency and Psychiatric Disorders -- 1 Introduction -- 2 The Association Between ID and Psychiatric Disorders -- 2.1 Anxiety Disorders -- 2.2 Depressive Disorders -- 2.3 Bipolar Disorders -- 2.4 Schizophrenia and Related Psychoses -- 2.5 ID and Women´s Mental Health -- 2.5.1 Premenstrual Syndrome (PMS) -- 2.5.2 Iron and Pregnancy -- 3 Explaining Mechanisms of the Relationship Between ID and Psychiatric Disorders -- 4 Iron Supplementation and Risk of Psychiatric Disorders -- 5 Conclusion -- References -- Chapter 12: Iron and Neurodevelopmental Disorders -- 1 Introduction -- 2 Role of Iron in Nervous System Development -- 3 Iron and Neurodevelopmental Disorders -- 3.1 Iron and Neural Tube Defects -- 3.2 Iron and Autism Spectrum Disorder -- 3.3 Iron and Attention-Deficit/Hyperactivity Disorder (ADHD) -- 4 Conclusion -- References -- Chapter 13: Iron and Neuropathies -- 1 Introduction -- 2 Iron and Nerve Conduction -- 3 Iron and Neuropathies -- 3.1 Optic Neuropathy -- 3.2 Neurodegeneration with Brain Iron Accumulation (NBIA) -- 3.2.1 Neuroferritinopathy. 3.2.2 Infantile Neuroaxonal Dystrophy. |
| Record Nr. | UNINA-9910635385103321 |
| Gateway East, Singapore : , : Springer, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chimie et cerveau / / collection dirigée par Bernard Bigot
| Chimie et cerveau / / collection dirigée par Bernard Bigot |
| Autore | Agid Yves |
| Pubbl/distr/stampa | Les Ulis, France : , : EDP Sciences, , 2015 |
| Descrizione fisica | 1 online resource (214 pages) : illustrations (some color) |
| Disciplina | 612.822 |
| Collana | Collection Chimie Et |
| Soggetto topico |
Brain chemistry
Central nervous system Neuropharmacology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 2-7598-1894-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | fre |
| Nota di contenuto | Frontmatter -- Ont contribué à la rédaction de cet ouvrage -- Sommaire -- Avant-propos -- Préface -- Partie 1 Explorer le cerveau pour en comprendre le fonctionnement -- Chapitre 1 : La chimie des récepteurs des neurotransmetteurs -- Chapitre 2 : Imagerie moléculaire de la synapse -- Chapitre 3 : Imagerie fonctionnelle cérébrale -- Chapitre 4 : Fonctionnement du système nerveux : imagerie calcique et optogénétique -- Partie 2 Les pathologies dégénératives du cerveau et leur traitement -- Chapitre 5 : Vieillissement cérébral ou maladie dégénérative -- Chapitre 6 : La molécule et les maladies : protéines infectieuses -- Chapitre 7 : Maladie d’Alzheimer et cibles thérapeutiques : état de l’art -- Partie 3 Les pathologies psychiatriques du cerveau et leur traitement -- Chapitre 8 : Opiacés et cerveau -- Chapitre 9 : Aspect génétique des addictions -- Chapitre 10 : La dépression et ses traitements -- Partie 4 Les apports et enjeux de la chimie dans les neurosciences et la neuropharmacologie -- Chapitre 11 : Les enjeux de la chimie dans la connaissance du cerveau -- Chapitre 12 : La neuro-pharmacologie : un triomphe dans l’exploration du cerveau, un échec à dépasser dans la création de thérapeutiques innovantes |
| Record Nr. | UNINA-9910465223403321 |
Agid Yves
|
||
| Les Ulis, France : , : EDP Sciences, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chimie et cerveau / / collection dirigée par Bernard Bigot
| Chimie et cerveau / / collection dirigée par Bernard Bigot |
| Autore | Agid Yves |
| Pubbl/distr/stampa | Les Ulis, France : , : EDP Sciences, , 2015 |
| Descrizione fisica | 1 online resource (214 pages) : illustrations (some color) |
| Disciplina | 612.822 |
| Collana | Collection Chimie Et |
| Soggetto topico |
Brain chemistry
Central nervous system Neuropharmacology |
| ISBN | 2-7598-1894-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | fre |
| Nota di contenuto | Frontmatter -- Ont contribué à la rédaction de cet ouvrage -- Sommaire -- Avant-propos -- Préface -- Partie 1 Explorer le cerveau pour en comprendre le fonctionnement -- Chapitre 1 : La chimie des récepteurs des neurotransmetteurs -- Chapitre 2 : Imagerie moléculaire de la synapse -- Chapitre 3 : Imagerie fonctionnelle cérébrale -- Chapitre 4 : Fonctionnement du système nerveux : imagerie calcique et optogénétique -- Partie 2 Les pathologies dégénératives du cerveau et leur traitement -- Chapitre 5 : Vieillissement cérébral ou maladie dégénérative -- Chapitre 6 : La molécule et les maladies : protéines infectieuses -- Chapitre 7 : Maladie d’Alzheimer et cibles thérapeutiques : état de l’art -- Partie 3 Les pathologies psychiatriques du cerveau et leur traitement -- Chapitre 8 : Opiacés et cerveau -- Chapitre 9 : Aspect génétique des addictions -- Chapitre 10 : La dépression et ses traitements -- Partie 4 Les apports et enjeux de la chimie dans les neurosciences et la neuropharmacologie -- Chapitre 11 : Les enjeux de la chimie dans la connaissance du cerveau -- Chapitre 12 : La neuro-pharmacologie : un triomphe dans l’exploration du cerveau, un échec à dépasser dans la création de thérapeutiques innovantes |
| Record Nr. | UNINA-9910798347003321 |
|
Agid Yves
|
||
| Les Ulis, France : , : EDP Sciences, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chimie et cerveau / / collection dirigée par Bernard Bigot
| Chimie et cerveau / / collection dirigée par Bernard Bigot |
| Autore | Agid Yves |
| Pubbl/distr/stampa | Les Ulis, France : , : EDP Sciences, , 2015 |
| Descrizione fisica | 1 online resource (214 pages) : illustrations (some color) |
| Disciplina | 612.822 |
| Collana | Collection Chimie Et |
| Soggetto topico |
Brain chemistry
Central nervous system Neuropharmacology |
| ISBN | 2-7598-1894-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | fre |
| Nota di contenuto | Frontmatter -- Ont contribué à la rédaction de cet ouvrage -- Sommaire -- Avant-propos -- Préface -- Partie 1 Explorer le cerveau pour en comprendre le fonctionnement -- Chapitre 1 : La chimie des récepteurs des neurotransmetteurs -- Chapitre 2 : Imagerie moléculaire de la synapse -- Chapitre 3 : Imagerie fonctionnelle cérébrale -- Chapitre 4 : Fonctionnement du système nerveux : imagerie calcique et optogénétique -- Partie 2 Les pathologies dégénératives du cerveau et leur traitement -- Chapitre 5 : Vieillissement cérébral ou maladie dégénérative -- Chapitre 6 : La molécule et les maladies : protéines infectieuses -- Chapitre 7 : Maladie d’Alzheimer et cibles thérapeutiques : état de l’art -- Partie 3 Les pathologies psychiatriques du cerveau et leur traitement -- Chapitre 8 : Opiacés et cerveau -- Chapitre 9 : Aspect génétique des addictions -- Chapitre 10 : La dépression et ses traitements -- Partie 4 Les apports et enjeux de la chimie dans les neurosciences et la neuropharmacologie -- Chapitre 11 : Les enjeux de la chimie dans la connaissance du cerveau -- Chapitre 12 : La neuro-pharmacologie : un triomphe dans l’exploration du cerveau, un échec à dépasser dans la création de thérapeutiques innovantes |
| Record Nr. | UNINA-9910809821203321 |
|
Agid Yves
|
||
| Les Ulis, France : , : EDP Sciences, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fiber Pathways of the Brain [[electronic resource]]
| Fiber Pathways of the Brain [[electronic resource]] |
| Autore | Schmahmann Jeremy D |
| Pubbl/distr/stampa | Oxford, : Oxford University Press, USA, 2009 |
| Descrizione fisica | 1 online resource (673 p.) |
| Disciplina |
599.0188
612.825 |
| Soggetto topico |
Brain chemistry
Cerebral cortex Developmental neurobiology Myelinated neurofibrils Nerve Fibers, Myelinated |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-12533-8
9786612125331 0-19-972826-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Foreword; Contents; Part I: Relevance of the Cerebral White Matter Fiber Pathways; Part II: Approach to the Study of the Fiber Tracts; Part III: White Matter Fiber Bundles by Cortical Region of Origin; Part IV: Connectional Topography and Putative Functional Roles of Individual Fiber Bundles; Part V: Composite Summary of Cerebral White Matter Fiber Systems in the Rhesus Monkey; Part VI: Functional Considerations; Notes; Abbreviations; References; Index |
| Record Nr. | UNINA-9910454473003321 |
|
Schmahmann Jeremy D
|
||
| Oxford, : Oxford University Press, USA, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fiber Pathways of the Brain [[electronic resource]]
| Fiber Pathways of the Brain [[electronic resource]] |
| Autore | Schmahmann Jeremy D |
| Pubbl/distr/stampa | Oxford, : Oxford University Press, USA, 2009 |
| Descrizione fisica | 1 online resource (673 p.) |
| Disciplina |
599.0188
612.825 |
| Soggetto topico |
Brain chemistry
Cerebral cortex Developmental neurobiology Myelinated neurofibrils Nerve Fibers, Myelinated |
| ISBN |
1-282-12533-8
9786612125331 0-19-972826-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Foreword; Contents; Part I: Relevance of the Cerebral White Matter Fiber Pathways; Part II: Approach to the Study of the Fiber Tracts; Part III: White Matter Fiber Bundles by Cortical Region of Origin; Part IV: Connectional Topography and Putative Functional Roles of Individual Fiber Bundles; Part V: Composite Summary of Cerebral White Matter Fiber Systems in the Rhesus Monkey; Part VI: Functional Considerations; Notes; Abbreviations; References; Index |
| Record Nr. | UNINA-9910782803803321 |
|
Schmahmann Jeremy D
|
||
| Oxford, : Oxford University Press, USA, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Brain chemistry
(22)
- Brain - Physiology (4)
- Amino acids (3)
- Aromatic compounds (3)
- Brain - Anatomy (3)